In vitro anti-inflammatory effect of apigenin in the Helicobacter pylori-infected gastric adenocarcinoma cells

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 376-383

  Wang, Yuan Chuen ^a   Huang, Kai Ming ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Apigenin; Gastric cancer; Helicobacter pylori; Inflammation; Oxidative burst

Indexed keywords

APIGENIN; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MUCIN 2; REACTIVE OXYGEN METABOLITE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG STRUCTURE; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; STOMACH CARCINOMA;

ANTI-INFLAMMATORY AGENTS; APIGENIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLOOXYGENASE 2; EPITHELIAL CELLS; FRUIT; HELICOBACTER PYLORI; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MUCIN-2; NF-KAPPA B; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; VEGETABLES;

HELICOBACTER PYLORI;

EID: 84872467421     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.12.018     Document Type: Article

References (34)

1. Anonymous World Health Organization IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. vol. 61 1994, World Health Organization, Geneva, 177-240.
2. Anonymous Helicobacter pylori CagA as a potential bacterial oncoprotein in gastric carcinogenesis. Pathol. Biol. 2003, 51:393-394.
3. Bonizzi G., Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. TRENDS Immunol. 2004, 25:280-288.
4. Cho S.O., Lim J.W., Kim K.H., Kim H. Involvement of Ras and AP-1 in the Helicobacter pylori-induced expression of COX-2 and iNOS in gastric epithelial AGS cells. Dig. Dis. Sci. 2010, 55:988-996.
5. Covacci S., Telford J.L., Giuseppe G.D., Parsonnet J., Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999, 284:1328-1333.
6. Crantree J.E., Naumann M. Epithelial cell signaling in Helicobacter pylori infection. Current Signal Transduction Therapy 2006, 1:53-56.
7. Das A., Banik N.L., Ray S.K. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but in human normal astrocytes. Cancer 2010, 116:164-176.
8. D'Elios M.M., Andersen L.P. Helicobacter pylori inflammation, immunity, and vaccines. Helicobacter 2007, 12(Suppl. 1):15-19.
9. D'Elios M.M., Andersen L.P. Helicobacter pylori inflammation, immunity, and vaccines for Helicobacter pylori. Helicobacter 2009, 14(Suppl. 1):21-28.
10. Ding Z.S., Minohara Y., Fan X.J., Wang J., Reyes V.E., Patel J., Dirden-Kramer B., Boldogh I., Ernst P.B., Crowe S.E. Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect. Immun. 2007, 75:4030-4039.
11. Forman D., Newekk D.G., Fullerton F., Yarnell J.W.G., Stacey A.R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J. 1991, 302:1302-1305.
12. 2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem. Int. 2008, 52:878-886.
13. Han R.M., Tian Y.X., Liu Y., Chen C.H., At X.C., Zhang J.P., Skibsted L.H. Comparison of flavonoids and isoflavonoids as antioxidants. J. Agric. Food Chem. 2009, 57:3780-3785.
14. Handa O., Naito Y., Yoshikawa T. Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflamm. Res. 2010, 59:997-1003.
15. Jobin C., Sartor R.B. The IκB/NF-κB system: a key determinant of mucosal inflammation and protection. Am. J. Physiol. Cell Physiol. 2000, 278:C451-C462.
16. Jocobs Marc D., Harrison Stephen C. Stuctures of an IκB/NF-κB complex. Cell 1998, 95:749-758.
17. Kim Y.J., Chung J.W., Lee S.J., Choi K.S., Kim J.H., Hahm K.B. Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng. J. Clin. Biochem. Nutr. 2010, 46:195-204.
18. Konturek P.C., Konturek S.J., Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis. J. Physiol. Pharmacol. 2009, 60:3-21.
19. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulation in apoptosis and necrosis. Annu. Res. Physiol. 1998, 60:619-642.
20. Kufe Donald.W. Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer 2009, 9:874-885.
21. Lambeth J.D. Nox enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4:181-189.
22. Lee J.H., Zhou H.Y., Cho S.Y., Kim Y.S., Lee Y.S., Jeong S. Anti-inflammatory mechanisms of apigenin: Inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Arch. Pharm. Res. 2007, 30:1318-1327.
23. Leopoldini M., Pitarch I.P., Toscano M. Structure, conformation, and electronic properties of apigenin, luteolin, and taxifolin antioxidant. A first principle theoretical study. J. Phys. Chem. A 2004, 108:92-96.
24. Miean K.H., Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem. 2001, 49:3106-3112.
25. Montecucco C., Rappuoli R. Living dangerously; How Helicobacter pylori survives in the human stomach. Nat. Rev. Mol. Cell Biol. 2001, 2:457-466.
26. Naito Y., Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med. 2002, 33:323-336.
27. Nicholas C., Batra S., Vargo M.A., Voss O.H., Gavrilin M.A., Wewers M.D., Guttridge D.C., Grotewold E., Doseff A.I. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-{kappa}B through the suppression of p65 phosphorylation. J. Immunol. 2007, 179:7121-7127.
28. Pauloina T., Dutot M., Warneta J.M., Rata R. In vitro modulation of preservative toxicity: High molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. Eur. J. Pharm. Sci. 2008, 34:263-273.
29. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinoma. Nat. Rev. Cancer 2002, 2:28-37.
30. Peek J.R.R.M., Fiske C., Wilson K.T. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol. Rev. 2010, 90:831-858.
31. 1 (ginseng) and parthenolide (feverfew). Food Chem. Toxicol. 2003, 41:1381-1390.
32. Wright B., Moraes L.A., Kemp C.F., Mullen W., Crozier A., Lovegrove J.A., Gibbins J.M. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Br. J. Pharmacol. 2010, 159:1312-1325.
33. Yuan L.H., Xia W., Zhao X.J., Zhang X.H., Zhang Wu.K.L. Inhibition of PKB/Akt activity involved in apigenin-induced apoptosis in human gastric carcinoma cells. Chin. Sci. Bull. 2007, 52:2226-2232.
34. Zhang L., Kong Y., Wu D., Zhang H., Wu J., Chen J., Ding J., Hu L., Jiang H., Shen X. Three flavonoids targeting the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: crystal structure characterization with enzymatic inhibition assay. Protein Sci. 2008, 17:1971-1978.